Sep 06, 2016 12:01 pm UTC| Business
ATLANTA, Sept. 06, 2016 -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from an...
Sep 06, 2016 12:01 pm UTC| Business
NEW YORK, Sept. 06, 2016 -- PHI Group (www.phiglobal.com)(OTC Markets:PHIL), a U.S. diversified holding company engaged in mergers and acquisitions announced today that Milost Advisors Inc has completed all aspects of...
Sep 06, 2016 12:01 pm UTC| Business
NEW YORK, Sept. 06, 2016 -- PHI Group (www.phiglobal.com)(OTC Markets:PHIL), a U.S. diversified holding company engaged in mergers and acquisitions announced today that Milost Advisors Inc has completed all aspects of...
Advaxis to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Sep 06, 2016 12:01 pm UTC| Business
PRINCETON, N.J., Sept. 06, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O’Connor, president and chief executive officer of...
Advaxis to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Sep 06, 2016 12:01 pm UTC| Business
PRINCETON, N.J., Sept. 06, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O’Connor, president and chief executive officer of...
Sep 06, 2016 12:01 pm UTC| Business
BERKELEY, Calif., Sept. 06, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the appointment of Natalie R. Sacks, M.D., to the position of chief medical officer. “Dr. Sacks’ clinical background as well as her...
Sep 06, 2016 12:01 pm UTC| Business
BERKELEY, Calif., Sept. 06, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the appointment of Natalie R. Sacks, M.D., to the position of chief medical officer. “Dr. Sacks’ clinical background as well as her...